Online Only Articles

Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the European Group for Blood and Marrow Transplant Chronic Malignancies Working Party

Hematology, Centre Hospitalier Lyon-Sud, Pierre-Benite, France
Hematology, Centre Hospitalier Lyon-Sud, Pierre-Benite, France
Histocompatibility, Etablissement Français du Sang, Lyon, France
Biostatistics, University Tor Vergata, Rome, Italy
EBMT Data Office, Leiden, the Netherlands
EBMT Data Office, Leiden, the Netherlands
CHU Lapeyronie, Montpellier, France
CHU Bordeaux, France
University Hospital of Freiburg, Germany
Institut Paoli-Calmettes, Marseille, France
Haga Hospital, The Hague, the Netherlands
VU University Medical Center, Amsterdam, the Netherlands
Leiden University Medical Center, the Netherlands
University Medical Centre, Utrecht, the Netherlands
Nottingham University, UK
Manchester Royal Infirmary, UK
University Hospital, Basel, Switzerland
Hopital Michallon, Grenoble, France
University Hospital Gasthuisberg, Leuven, Belgium
CHU Nantes, France
Hopital La Miletrie, Poitiers, France
HUCH Comprehensive Cancer Center, Helsinki, Finland
CHRU, Angers, France
Nouvel Hopital Civil, Strasbourg, France
University Hospital of Liege, Belgium
Eurocord - Hopital St Louis, Paris, France
Hospital Saint-Antoine, Paris, France
Hospital Saint-Antoine, Paris, France
University Hospital Eppendorf, Hamburg, Germany
Vol. 102 No. 7 (2017): July, 2017 https://doi.org/10.3324/haematol.2017.165399